Category: Cost Alert

High Drug Prices Are a Major Challenge for Patients and Providers

Innovative medical treatments have the potential to prevent, treat, and cure diseases, but not if the patients who need the medications can’t afford them. A recent Wall Street Journal article shared the patient and provider perspectives of this growing problem. Continue reading

Posted in: Cost Alert

Pharma’s Red Herring

Whenever drugmakers can’t come up with a sound argument against good policy, they roll out their time-tested “price controls” diversion. Please. Continue reading

Posted in: Cost Alert

What do consumers really think about drug prices?

Echoing June’s Kaiser Health Tracking Poll, the latest survey again shows a large majority of consumers (72 percent) – especially those currently taking prescription drugs (77 percent) – say the cost of medical treatments is unreasonable. Continue reading

Posted in: Cost Alert, Health Care Costs

Consumers ‘held hostage’ by soaring drug prices

Exorbitant prescription drug prices are hitting patients hard, forcing most to cut back on household expenses like food so they can afford their medications. Those are the results of a new survey from Consumer Reports, which also found that rising drug prices are inhibiting patients’ ability to pay for other medical care. Continue reading

Posted in: Cost Alert

Prescription drugs push spending growth higher

Spending on prescription drugs are escalating faster than all other major health care categories, increasing at a whopping 9.4 percent. Continue reading

Posted in: Cost Alert

Pricey Hep C Drugs to Blame for Higher Health Care Spending

Gilead’s Solvaldi and Harvoni – which ring in price tags at $1,000 or more per pill – were leading culprits behind the 12.6 percent prescription drug spending increase in 2014. Continue reading

Posted in: Cost Alert

Improper patents lead to substantially higher drug costs

The problem of wrongly granted patents leads to higher prices for patients, small and large employers, Medicare, and Medicaid – not to mention billions of dollars of “pure economic waste,” according to a new report from the Center for Economic and Policy Research. Continue reading

Posted in: Cost Alert

Durham Op-Ed: “The Great Threat of Rising Health Care Costs”

Today’s Morning Consult features an op-ed by AHIP Interim CEO Dan Durham, in which he states now is the time to focus on ensuring health care accessibility, affordability, and quality. However, Durham highlights underlying challenges that all stakeholders need to confront in order to move the health system forward. Continue reading

Posted in: AHIP in the News, Cost Alert

Striking down weak patents protects patients

In some cases, explosive drug prices are the result of drugmakers’ patent schemes that financially distress consumers and limit their treatment options. That is why a recent proposal to exempt pharmaceutical companies from a key consumer protection would leave families across the country even more hostage to egregious pharmaceutical prices. Continue reading

Posted in: AHIP Letters, Cost Alert

Hill Briefing Examines the Truth About Premiums

Influential factors that go into premiums took center stage this afternoon at a Capitol Hill briefing hosted by centrist think tank Third Way. The panelists all emphasized the fact that proposed premiums vary greatly; and therefore, it’s crucial to consider the full picture when looking at changes in premiums. Continue reading

Posted in: Cost Alert, On The Hill